PRESS RELEASES
Insights into m6A methylation in Autism
Our work integrates recent advances in epitranscriptomics and discusses how m6A RNA methylation may contribute to ASD development, neurodevelopmental alterations, synaptic dysfunction, and behavioral manifestations. Importantly, highlight the role of m6A methylation in synaptic enrichment of high-risk autism genes. Read More
About SKAN Research Trust
SKAN is a Bengaluru-based not-for-profit medical research trust focussed on transformational technologies that will alter the future of medicine through the discovery of new therapies. SKAN’s areas of expertise include human genomics, stem cells, gut microbiome, molecular biology, and transformational artificial intelligence applied to areas of ageing and neurological ailments to achieve breakthrough therapies.
Website: skanrt.in
Media contact: contactus@skanrt.in
Careers: talent@skanrt.in